It is always difficult for doctors to predict the cancer patient’s response to radiation. This uncertainty can also bring tension between doctors and patient attenders. The new device designed by the scientists from U.S. is expected to give some relief to doctors in predicting the radiation response.

Engineered bone marrow developed in a novel microfluidic chip device responds to damaging radiation exposure followed by treatment with compounds that aid in blood cell recovery in a way that mimics living bone marrow. This new bone marrow-on-a-chip micro-device holds promise for both predicting radiation response and testing and developing improved radiation countermeasures. The article is published on the Tissue Engineering website until June 4, 2016. Scientists from Harvard University (Boston and Cambridge, MA), Children's Hospital Boston and Harvard Medical School have shown that the…